Back to 
Farallon Capital Management, L.L.C.
Farallon Capital Management, L.L.C.
SLS
2 quarters
Position history for Farallon Capital Management, L.L.C.'s holdings in SELLAS Life Sciences Group, Inc.
No. Farallon Capital Management exited its SLS (SELLAS Life Sciences Group) position in Q2 2026. Its Q1 2026 13F listed 40,000 shares worth $169,200. Farallon Capital Management first reported SLS in Q1 2026 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$169,200
Total Shares Change
-40,000
Quarter-by-Quarter History